Vandana Anang
Immunology and Microbiology · The Ohio State University
Publications
22
Citations
238
Est. group size
~3
Recurring co-author estimate
Active years
11
Publishing since 2015
Vandana Anang's research examines how immune cells and cellular signaling pathways (including ubiquitin-proteasome regulation, mitochondrial metabolism, and programmed cell death proteins like Bcl-2) influence infections such as tuberculosis, influenza, and COVID-19, as well as cancer progression and immune evasion. The work spans macrophage and dendritic cell responses, host-pathogen interactions, and potential therapeutic strategies targeting metabolic and protein-degradation pathways.
Publication output was minimal or absent from 2017-2019 but has grown steadily since 2020, reaching its highest annual count in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis
Journal of Experimental & Clinical Cancer Research · 2025
- A New Role for Bcl-2 Interacting Killer (BIK) in COVID-19 Pathogenesis
American Journal of Respiratory and Critical Care Medicine · 2025
- The Host Ubiquitin E3 Ligase ARIH2 Reduces Influenza A Virus Replication in the Airways and Mitigates Disease Progression in Mice
American Journal of Respiratory and Critical Care Medicine · 2025
- Mitochondria driven innate immune signaling and inflammation in cancer growth, immune evasion, and therapeutic resistance
International review of cell and molecular biology · 2024
- Tumor microenvironment induced switch to mitochondrial metabolism promotes suppressive functions in immune cells
International review of cell and molecular biology · 2024
- Targeting the Ubiquitin Proteasome System to Combat Influenza A Virus: Hijacking the Cleanup Crew
Reviews in Medical Virology · 2024
- Identifying quantitative sncRNAs signature using global sequencing as a potential biomarker for tuberculosis diagnosis and their role in regulating host response
International Journal of Biological Macromolecules · 2024
- Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology
Frontiers in Pharmacology · 2023
- HSP-27 and HSP-70 negatively regulate protective defence responses from macrophages during mycobacterial infection
Microbes and Infection · 2023
- Mycobacteria modulate SUMOylation to suppresses protective responses in dendritic cells
PLoS ONE · 2023
- Butyrate induces oxidative burst mediated apoptosis via Glucose-6-Phosphate Dehydrogenase (G6PDH) in macrophages during mycobacterial infection
Microbes and Infection · 2023
- Role of lymphocytes, macrophages and immune receptors in suppression of tumor immunity
Progress in molecular biology and translational science · 2022
- Receptors of immune cells mediates recognition for tumors
Progress in molecular biology and translational science · 2022
- Bcl2 negatively regulates Protective Immune Responses During <i>Mycobacterial</i> Infection
BioMolecular Concepts · 2021
- Calcium Dynamics Regulate Protective Responses and Growth of <i>Staphylococcus aureus</i> in Macrophages
BioMolecular Concepts · 2020
- International review of cell and molecular biology×2
- Microbes and Infection×2
- Progress in molecular biology and translational science×2
- BioMolecular Concepts×2
- American Journal of Respiratory and Critical Care Medicine×2
- Haoxin Zhao
Immunology and Microbiology · The Ohio State University
- Anthony Cannon
Immunology and Microbiology · Indiana University
- Megan Duggan
Immunology and Microbiology · The Ohio State University
- Gang Xin
Immunology and Microbiology · The Ohio State University
- Stanley Ching‐Cheng Huang
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile